Pediatric catastrophic antiphospholipid syndrome with extensive skin involvement

Area of Science:

• Pediatric Rheumatology
• Hematology
• Critical Care Medicine

Background:

• Antiphospholipid syndrome (APS) is characterized by persistent antiphospholipid antibodies, leading to hypercoagulability.
• Catastrophic Antiphospholipid Syndrome (CAPS) is a rare, life-threatening variant of APS with high morbidity and mortality.
• CAPS involves rapid, widespread thrombosis across multiple organs, necessitating prompt diagnosis and intensive treatment.

Observation:

• A pediatric case of CAPS presented with extensive cutaneous involvement.
• The CAPS was precipitated by an underlying infection.
• The patient experienced severe, widespread thrombotic events affecting multiple organ systems.

Findings:

• Successful management of pediatric CAPS was achieved through a multi-faceted therapeutic approach.
• Treatment included high-dose systemic corticosteroids and antibiotics to address inflammation and infection.
• Long-term anticoagulation and diligent wound care were crucial for recovery and preventing recurrence.

Implications:

• This case underscores the importance of early recognition and aggressive management of pediatric CAPS.
• A combined treatment strategy involving immunosuppression, infection control, anticoagulation, and supportive care can be effective.
• Effective management of severe cutaneous manifestations in CAPS is vital for patient outcomes.